← Leaderboards
Luis Francisco Diaz
Oregon Health & Science University
$108,512
Attributed
$108,512
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2024–25$100K$75K$50K$25K$0
'24
'25
Funding mix
By agency
NIH$108,512 · 1
By mechanism
F31$108,512 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Ramon Francisco Barajas$2,483,416
- Lisa M Coussens$10,998,130
- Zheng David Qian$4,913,102
- Emek Demir$947,940
- Philip R Streeter$5,401,011
Others in their field
Other Rising Stars on “Aspartate Transaminase”
- Ethan Perlstein · Maggie'S Pearl, Llc$1,805,996
- Roderick O'Connor · University Of Pennsylvania$1,033,945
- Prasad Manchem · Pleiogenix Inc.$295,923
- Victor Garcia · New York Medical College$164,000
- Roy Cohen · Tet Medical$162,481
- David Fischell · Tet Medical$162,481
Research focus
Aspartate TransaminaseAtac-SeqBindingBioinformaticsBiologicalCancer EtiologyCandidate IdentificationCdkn2a GeneCell LineCellsCessation Of LifeChemotherapy And/Or RadiationChip-SeqCrispr/Cas TechnologyCytotoxic T-LymphocytesDendritic CellsDesignDiagnosisDifferential ExpressionDisseminated Malignant NeoplasmDistalDown-RegulationDoxycyclineAdenocarcinoma Cell
Grant awards (2)
Defining the role of the mitochondrial protein, GOT2, in pancreatic cancer metastasis and epigenetic dysregulation$54,538
F31 · FY2025 · CA · contact PI
Defining the role of the mitochondrial protein, GOT2, in pancreatic cancer metastasis and epigenetic dysregulation$53,974
F31 · FY2024 · CA · contact PI